Feb. 16 – On Tuesday, Australia’s medical regulator approved the use of AstraZeneca and Oxford University’s COVID-19 vaccine as the country prepares to begin inoculating its people next week against the coronavirus. The Therapeutic Good Administration confirmed Tuesday that for those 18 years of age and older, the two-dose vaccine regimen has been registered for use.
The TGA has reviewed all available evidence from a regulatory perspective and concluded that the AstraZeneca vaccine can be safely administered 4-12 weeks apart,”The TGA, from a regulatory perspective, has reviewed all the available evidence and determined that the AstraZeneca vaccine can be safely administered 4-12 weeks apart,” “The TGA has rigorously evaluated all clinical trial data and information provided by AstraZeneca, and has issued provisional approval.”
On Tuesday, Prime Minister Scott Morrison told reporters that the initial supply of the AstraZeneca drug would be imported, but will be developed within months in the country.After giving the OK to the one developed by the U.S. pharmaceutical company Pfizer and Germany’s biotech company BioNTech in late January for those 16 years of age and older, it is the second vaccine Australia has approved for use.
On Monday, Minister of Health Greg Hunt announced that the first Pfizer shooting shipments had arrived in the country.During Tuesday’s press conference, Hunt said Australia’s vaccine roll-out is scheduled to begin with the inoculation of workers and residents with the Pfizer vaccine at 240 elderly care facilities on Monday.That’s a very important move forward in protecting our older Australians,”That’s a very important step forward in protecting our older Australians,”
53.8 million doses of the AstraZeneca-Oxford vaccine have been secured by Australia, with hopes that 3.8 million doses will arrive in the country earlier this year and the remaining 50 million will be manufactured at Australian facilities. With the option of purchasing more if supply is open, the country expects to obtain 10 million Pfizer doses earlier this year.It also deals with at least 51 million doses of Novavax if that vaccine receives regulatory approval and with an additional 25 million doses from the World Health Organization’s COVAX Factory.
Through these four deals, the Australian government has said it has spent more than $2.56 billion.”Our vaccination program is on track,” Morrison said. “Our vaccination program has the backing of Australia’s best medical experts and that means that we can proceed along the path that we have set out.”On Tuesday, the health authorities reported five cases of the virus—two local and three imported transmissions—within the past 24 hours, for a total case load of 28,905, including 909 deaths. The World Health Organization declared the status of emergency use of the AstraZeneca vaccine on Monday.